Delivery Order SPE2DB22D1106-SPE2DB25FFAL1
- Not listed
- The Defense Logistics Agency awarded a $82,059.20 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Menopur 75 Unit Vials. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is scheduled for completion by July 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $8,036.71 delivery order to AmerisourceBergen Drug Corp for Menopur 75 Unit Vials, with an ultimate completion date of July 24, 2025. This contract employs firm fixed pricing and was competitively awarded with no set-aside designation. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $47,817.37 delivery order to AmerisourceBergen Drug Corp for MENOPUR 75 Unit Vials under a firm fixed-price contract. The order was competitively awarded with no set-aside designation and is scheduled for completion by July 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $100,913.29 firm-fixed-price contract is for the supply of 4,565,055,511 units of Menopur 75 unit vials, with a period of performance through July 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $137,960.35, is a Delivery Order for the procurement of 4,567,754,856 units of MENOPUR 75 UNIT VIALS. The contract has a Firm Fixed Price pricing type and an ultimate completion date of April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,732.03, is for the delivery of MENOPUR 75 unit vials. It is a Firm Fixed Price contract with a completion date of May 10, 2023. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MENOPUR 75 unit vials. The contract, valued at $154,288.28, has an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $18,613.26 firm fixed price delivery order is for the supply of Menopur 75 unit vials, a specialty pharmaceutical product. The award falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to $999,999,999.00, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) has awarded a $8,272.56 Firm Fixed Price Delivery Order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,595,693 units of Menopur 75 Unit Vials. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities in support of military...
- This federal contract award, valued at $34,197.40, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENOPUR 75 UNIT VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 7, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAL1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $103,790.69 to AmerisourceBergen Drug Corp for the supply of Menopur 75 Unit Vials. This competitively awarded, firm fixed-price contract was executed on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the pharmaceutical distributor to supply a comprehensive range of medical commodities and medications to support military healthcare systems worldwide. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills such orders through competitive procurement channels, demonstrating its capability to meet federal healthcare supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $103.8k | 7/29/25 |